miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer
- PMID: 35955652
- PMCID: PMC9369015
- DOI: 10.3390/ijms23158518
miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer
Abstract
Lung cancer is the leading cause of cancer death worldwide. miR-199a, which has two mature molecules: miR-199a-3p and miR-199a-5p, plays an important biological role in the genesis and development of tumors. We collected recent research results on lung cancer and miR-199a from Google Scholar and PubMed databases. The biological functions of miR-199a in lung cancer are reviewed in detail, and its potential roles in lung cancer diagnosis and treatment are discussed. With miR-199a as the core point and a divergence outward, the interplay between miR-199a and other ncRNAs is reviewed, and a regulatory network covering various cancers is depicted, which can help us to better understand the mechanism of cancer occurrence and provide a means for developing novel therapeutic strategies. In addition, the current methods of diagnosis and treatment of lung cancer are reviewed. Finally, a conclusion was drawn: miR-199a inhibits the development of lung cancer, especially by inhibiting the proliferation, infiltration, and migration of lung cancer cells, inhibiting tumor angiogenesis, increasing the apoptosis of lung cancer cells, and affecting the drug resistance of lung cancer cells. This review aims to provide new insights into lung cancer therapy and prevention.
Keywords: drug resistance; glucose metabolism; interplay; lung cancer; miR-199a; non-coding RNAs.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer.Int J Biol Sci. 2022 Jun 27;18(10):4187-4202. doi: 10.7150/ijbs.70312. eCollection 2022. Int J Biol Sci. 2022. PMID: 35844793 Free PMC article.
-
Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.Endocr J. 2021 May 28;68(5):583-597. doi: 10.1507/endocrj.EJ20-0353. Epub 2021 Mar 20. Endocr J. 2021. PMID: 33612561
-
[Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p].Zhongguo Fei Ai Za Zhi. 2023 Jul 20;26(7):479-486. doi: 10.3779/j.issn.1009-3419.2023.102.27. Zhongguo Fei Ai Za Zhi. 2023. PMID: 37653011 Free PMC article. Chinese.
-
Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.Biomed Pharmacother. 2022 Feb;146:112600. doi: 10.1016/j.biopha.2021.112600. Epub 2021 Dec 27. Biomed Pharmacother. 2022. PMID: 34968919
-
miR-137: a potential therapeutic target for lung cancer.Front Cell Dev Biol. 2024 Aug 23;12:1427724. doi: 10.3389/fcell.2024.1427724. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39247624 Free PMC article. Review.
Cited by
-
The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential.Int J Mol Sci. 2025 Apr 15;26(8):3736. doi: 10.3390/ijms26083736. Int J Mol Sci. 2025. PMID: 40332376 Free PMC article. Review.
-
Lentinan progress in inflammatory diseases and tumor diseases.Eur J Med Res. 2024 Jan 3;29(1):8. doi: 10.1186/s40001-023-01585-7. Eur J Med Res. 2024. PMID: 38172925 Free PMC article. Review.
-
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z. Signal Transduct Target Ther. 2025. PMID: 40675967 Free PMC article. Review.
-
Functional impact of multi-omic interactions in lung cancer.Front Genet. 2024 Feb 8;15:1282241. doi: 10.3389/fgene.2024.1282241. eCollection 2024. Front Genet. 2024. PMID: 38389572 Free PMC article.
-
Overexpression of miR-199b-5p in Colony Forming Unit-Hill's Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression.Int J Mol Sci. 2024 Jul 25;25(15):8087. doi: 10.3390/ijms25158087. Int J Mol Sci. 2024. PMID: 39125657 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical